Synonyms: amlodipine besylate | amlodipine maleate | Copalia® (amlodipine + valsartan) | Katerzia® (amlodipine oral suspension, 1 mg/mL) | Norvasc® | UK-4834011
amlodipine is an approved drug (FDA (1992), EMA (2007))
Compound class:
Synthetic organic
Comment: Amlodipine is a long-acting dihydropyridine class calcium channel blocker.
Amlodipine is on the World Health Organisation's List of Essential Medicines. Click here to access the pdf version of the WHO's 21st Essential Medicines list (2019). Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖View more information in the IUPHAR Pharmacology Education Project: amlodipine |
|
No information available. |
Summary of Clinical Use |
Used in the treatment of hypertension and chronic stable angina. Amlodipine is a component of the fixed-ratio drug Caduet® (marketed as Envacar® in some countries) which also contains the HMG-CoA inhibitor atorvastatin. Caduet® was first approved by the US FDA in 2004. Amlodipine is also a component of Prestalia®, a mixture of amlodipine and perindopril, a drug approved (by the US FDA in 2015) for the treatment of hypertension. EMA approvals are for fixed-dose combinations of amlodipine and the AT1 receptor antagonist valsartan. |
Mechanism Of Action and Pharmacodynamic Effects |
For an overview of the mechanism of action of amlodipine, please use the DrugBank link on the Summary tab. |